Finished Dosage Facility, Dehradun
Feb 13th 2013
Hyderabad based NATCO Pharma Limited has recorded improved operating results for the quarter and nine-months ended on 31st December, 2012.
The Board has also recommended payment of an interim dividend of Rs.4 per equity share, payable on 6th March, 2013
The following are the highlights of the consolidated operational performance.
Rs. Lakhs
| Quarter ended on | Nine months ended on | |||
|---|---|---|---|---|
| 31-Dec-2012 | 31-Dec-2011 | 31-Dec-2012 | 31-Dec-2011 | |
| Gross Revenues | 19091 | 14578 | 53240 | 40450 |
| Profit Before Tax | 3320 | 2204 | 8377 | 6185 |
| Profit After Tax | 2259 | 1700 | 6054 | 4696 |
| Increase in Revenues (YOY) | 31% | 32% | ||
| Increase in PAT | 33% | 29% | ||
The increase in revenues was driven by API and formulation exports. Out of the total revenues for the nine months period ended on 31st December, 2012, exports accounted for 47% at Rs. 213 Crores.